Trial
NCT05330208
Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-1816 in Healthy Subjects
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Beijing Suncadia Pharmaceuticals Co., Ltd
Collaborators
—
Condition
Diabetes
Intervention
SHR-1816
Why stopped
Sponsor internal strategy change.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-20